Fiet J - Search Results

1

Argon laser induced autofluorescence may distinguish between normal and tumor human urothelial cells: a microspectrofluorimetric study.

Anidjar M, Cussenot O, Blais J, Bourdon O, Avrillier S, Ettori D, Villette JM, Fiet J, Teillac P, Le Duc A. Anidjar M, et al. Among authors: fiet j. J Urol. 1996 May;155(5):1771-4. J Urol. 1996. PMID: 8627881

2

Distinct androgen 5 alpha-reduction pathways in cultured fibroblasts and immortalized epithelial cells from normal human adult prostate.

Boudou P, Cussenot O, Sollman H, Villette JM, Teillac P, Le Duc A, Fiet J. Boudou P, et al. Among authors: fiet j. J Urol. 1994 Jul;152(1):226-31. doi: 10.1016/s0022-5347(17)32867-7. J Urol. 1994. PMID: 8201672

3

Plasma neuroendocrine markers in patients with benign prostatic hyperplasia and prostatic carcinoma.

Cussenot O, Villette JM, Valeri A, Cariou G, Desgrandchamps F, Cortesse A, Meria P, Teillac P, Fiet J, Le Duc A. Cussenot O, et al. Among authors: fiet j. J Urol. 1996 Apr;155(4):1340-3. J Urol. 1996. PMID: 8632569

4

Assessment of microsatellite instability in urine in the detection of transitional-cell carcinoma of the bladder.

Mourah S, Cussenot O, Vimont V, Desgrandchamps F, Teillac P, Cochant-Priollet B, Le Duc A, Fiet J, Soliman H. Mourah S, et al. Among authors: fiet j. Int J Cancer. 1998 Dec 18;79(6):629-33. doi: 10.1002/(sici)1097-0215(19981218)79:6<629::aid-ijc13>3.0.co;2-1. Int J Cancer. 1998. PMID: 9842973

5

Telomerase activity as a potential marker in preneoplastic bladder lesions.

Lancelin F, Anidjar M, Villette JM, Soliman A, Teillac P, Le Duc A, Fiet J, Cussenot O. Lancelin F, et al. Among authors: fiet j. BJU Int. 2000 Mar;85(4):526-31. doi: 10.1046/j.1464-410x.2000.00466.x. BJU Int. 2000. PMID: 10691838

6

Non-invasive molecular detection of bladder cancer recurrence.

Amira N, Mourah S, Rozet F, Teillac P, Fiet J, Aubin P, Cortesse A, Desgrandchamps F, Le Duc A, Cussenot O, Soliman H. Amira N, et al. Among authors: fiet j. Int J Cancer. 2002 Sep 20;101(3):293-7. doi: 10.1002/ijc.10561. Int J Cancer. 2002. PMID: 12209982

7

FGF7/KGF triggers cell transformation and invasion on immortalised human prostatic epithelial PNT1A cells.

Ropiquet F, Huguenin S, Villette JM, Ronflé V, Le Brun G, Maitland NJ, Cussenot O, Fiet J, Berthon P. Ropiquet F, et al. Among authors: fiet j. Int J Cancer. 1999 Jul 19;82(2):237-43. doi: 10.1002/(sici)1097-0215(19990719)82:2<237::aid-ijc14>3.0.co;2-q. Int J Cancer. 1999. PMID: 10389758

8

Ultraviolet laser-induced autofluorescence distinction between malignant and normal urothelial cells and tissues.

Anidjar M, Cussenot O, Avrillier S, Ettori D, Villette JM, Fiet J, Teillac P, Le Duc A. Anidjar M, et al. Among authors: fiet j. J Biomed Opt. 1996 Jul;1(3):335-41. doi: 10.1117/12.239903. J Biomed Opt. 1996. PMID: 23014734 Free article. No abstract available.

9

Constitutive expression of FGF2/bFGF in non-tumorigenic human prostatic epithelial cells results in the acquisition of a partial neoplastic phenotype.

Ropiquet F, Berthon P, Villette JM, Le Brun G, Maitland NJ, Cussenot O, Fiet J. Ropiquet F, et al. Among authors: fiet j. Int J Cancer. 1997 Jul 29;72(3):543-7. doi: 10.1002/(sici)1097-0215(19970729)72:3<543::aid-ijc26>3.0.co;2-b. Int J Cancer. 1997. PMID: 9247302

10

Upregulation of endothelin 1 and its precursor by IL-1beta, TNF-alpha, and TGF-beta in the PC3 human prostate cancer cell line.

Le Brun G, Aubin P, Soliman H, Ropiquet F, Villette JM, Berthon P, Créminon C, Cussenot O, Fiet J. Le Brun G, et al. Among authors: fiet j. Cytokine. 1999 Feb;11(2):157-62. doi: 10.1006/cyto.1998.0407. Cytokine. 1999. PMID: 10089138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters